Immunome is a clinical-stage targeted oncology company focused on developing targeted therapies to improve outcomes for cancer patients. The company has an innovative portfolio of therapeutics, including antibody-drug conjugates and treatments for desmoid tumors.

Immunome

Immunome, Inc. | 6,762 followers on LinkedIn. Developing antibody-based therapeutics by unlocking the human memory B cell response. | Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens.

Michael Lefenfeld

Consultant - Pharmaceutical Development Operations

Robert Morgan

Global Quality Management Leader; Quality Compliance & Management Systems| Quality Assurance | Regulatory Expert | Manufacturing Operations

Yomara Gomez-Naiden

Principal Recruiter, Immunome

Erika Herbst

Immunome, Inc.

Exciting employment opportunities await you at Immunome! #hiring

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 16, 2024 3:20 PM	bad2b668
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 16, 2024 3:20 PM	27c8af9f
crunchbase trigger	general	Nov 16, 2024 3:20 PM	337c67bb
crunchbase profile	general	Nov 16, 2024 3:31 PM	cd7491e1
li profile	general	Nov 16, 2024 3:20 PM	e8d1f031
translate crunchbase fundingrounds	general
peers	general	Nov 16, 2024 3:20 PM	bca01ae8
news basic	general	Nov 16, 2024 3:20 PM	00be03ae
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:IMMUNOME

Immunome